Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-04-009498
Filing Date
2004-06-30
Accepted
2004-06-30 14:14:59
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K f99919a2e10vkza.htm 10-K/A 223165
2 EXHIBIT 21.1 f99919a2exv21w1.txt EX-21.1 190
3 EXHIBIT 23.2 f99919a2exv23w2.txt EX-23.2 1110
4 EXHIBIT 31.5 f99919a2exv31w5.txt EX-31.5 3532
5 EXHIBIT 31.6 f99919a2exv31w6.txt EX-31.6 3625
6 EXHIBIT 32.2 f99919a2exv32w2.txt EX-32.2 2133
7 GRAPHIC f99919a2f9991900.gif GRAPHIC 2850
8 GRAPHIC f99919a2f9991901.gif GRAPHIC 26232
  Complete submission text file 0000950134-04-009498.txt   265174
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-22570 | Film No.: 04890980
SIC: 2833 Medicinal Chemicals & Botanical Products